Skip to main content

Table 2 Clinical parameters for the study groups

From: Tissue inhibitor of metalloproteinase 4 in aqueous humor of patients with primary open angle glaucoma, pseudoexfoliation syndrome and pseudoexfoliative glaucoma and its role in proteolysis imbalance

 

Control

POAG

PXS

PXG

(n = 44)

(n = 36)

(n = 44)

(n = 44)

AGE(years)

75.27 ± 5.66 (63–86)

75.74 ± 7.4 (59–86) (p = 0.96)

75.76 ±5.15 (61–84) (p = 0.96)

75.96 ± 6.37 (64–88) (p = 0.96)

IOP (mm Hg)

14 ± 2.35 (9–17)

19 ±6.6 (10–40)

14.7 ± 3 (9–20)

21.1 ±9,3 (8–38)

Optic nerve c/d ratio

0.25 ± 0.053 (0.1–0.4)

0.62 ± 0.17 (0.4-0.9)

0.28 ±0.071 (0.2–0.4)

0.68 ± 0.16 (0.4–0.9)

Number of topical medications

nil

1 (49%)

nil

1 (9%)

 

2 (23%)

 

2 (13%)

 

3 (11%)

 

3 (47%)

 

4 (6%)

 

4 (22%)

  1. POAG: Primary open angle glaucoma, PXS: Pseudoexfoliation, PXG: Pseudoexfoliation glaucoma, c/d: cup-to-disc ratio. Results are presented as mean ± SD (range).
  2. p values refer to the comparison between each study group versus controls with the Kolmogorov-Smirnoff test.